1. Home
  2. ICG vs PYXS Comparison

ICG vs PYXS Comparison

Compare ICG & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

N/A

Current Price

$1.09

Market Cap

83.8M

Sector

Technology

ML Signal

N/A

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

N/A

Current Price

$1.38

Market Cap

71.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ICG
PYXS
Founded
2017
2018
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.8M
71.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ICG
PYXS
Price
$1.09
$1.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.25
$6.75
AVG Volume (30 Days)
28.8K
274.0K
Earning Date
02-26-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.03
EPS
N/A
N/A
Revenue
N/A
$13,858,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$0.84
52 Week High
$4.13
$5.55

Technical Indicators

Market Signals
Indicator
ICG
PYXS
Relative Strength Index (RSI) 29.59 41.12
Support Level $0.93 $1.29
Resistance Level $1.96 $1.69
Average True Range (ATR) 0.05 0.12
MACD 0.00 -0.00
Stochastic Oscillator 13.30 13.51

Price Performance

Historical Comparison
ICG
PYXS

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: